2001Chinese Journal of New Drugs and Clinical RemediesRequires access

Fluvastatin vs pravastatin in treating hyperlipidemia

He Xiao

Open publisher page 0 citations

Abstract

AIM: To observe and compare the antihyperlipidemia efficacy of fluvastatin vs pravasatin. METHODS: Fluvastatin group( n =41,M 22, F 19; age 60 a± s 8 a) was treated with fluvastatin 20 40 mg, po , qn for 4 wk. Pravastatin group( n =35, M 20, F 15; age 60 a±6 a) was treated with pravastatin 10 mg, po , qn for 4 wk. RESULTS: The total effective rate of fluvastatin for reducing TC was 92 %, it was higher than that of pravastatin 70 %( P 0.05). The total effective rates of flavastatin for reducing TG and raising HDL C were 61 % and 61 %, were similar to that of pravastatin 73 % and 69 %( P 0.05). Adverse reactions occurred in 8 patients of fluvastatin(20 %) and in 7 patients of pravastatin(20 %), but were mild in both groups. CONCLUSION: Fluvastatin is a safe and effective antihyperlipidemic drug, and fluvastatin is more effective than pravastatin in decreasing total cholesterol.

About this research paper

What this paper is about

AIM: To observe and compare the antihyperlipidemia efficacy of fluvastatin vs pravasatin. METHODS: Fluvastatin group( n =41,M 22, F 19; age 60 a± s 8 a) was treated with fluvastatin 20 40 mg, po , qn for 4 wk. Pravastatin group( n =35, M 20, F 15; age 60 a±6 a) was treated with pravastatin 10 mg, po , qn for 4 wk. RESULTS: The total effective rate of fluvastatin for reducing TC was 92 %, it was higher than that of pravastatin 70 %( P 0.05). The total effective rates of flavastatin for reducing TG and raising HDL C were 61 % and 61 %, were similar to that of pravastatin 73 % and 69 %( P 0.05). Adverse reactions occurred in 8 patients of fluvastatin(20 %) and in 7 patients of pravastatin(20 %), but were mild in both groups. CONCLUSION: Fluvastatin is a safe and effective antihyperlipidemic drug, and fluvastatin is more effective than pravastatin in decreasing total cholesterol.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To observe and compare the antihyperlipidemia efficacy of fluvastatin vs pravasatin. METHODS: Fluvastatin group( n =41,M 22, F 19; age 60 a± s 8 a) was treated with fluvastatin 20 40 mg, po , qn for 4 wk. Pravastatin group( n =35, M 20, F 15; age 60 a±6 a) was treated with pravastatin 10 mg, po , qn for 4 wk. RESULTS: The total effective rate of fluvastatin for reducing TC was 92 %, it was higher than that of pravastatin 70 %( P 0.05). The total effective rates of flavastatin for reducing TG and raising HDL C were 61 % and 61 %, were similar to that of pravastatin 73 % and 69 %( P 0.05). Adverse reactions occurred in 8 patients of fluvastatin(20 %) and in 7 patients of pravastatin(20 %), but were mild in both groups. CONCLUSION: Fluvastatin is a safe and effective antihyperlipidemic drug, and fluvastatin is more effective than pravastatin in decreasing total cholesterol.

Key concepts: Pravastatin, Fluvastatin, Hyperlipidemia, Medicine, Statin, Pharmacology, Adverse effect, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Fluvastatin vs pravastatin in treating hyperlipidemia — Research Paper | ScholarLens